Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Taking Less Blood for Lab Testing Reduces Transfusions in Intensive Care, Shows World-First Clinical Trial

By LabMedica International staff writers
Posted on 13 Oct 2023

Most hospitals utilize standard tubes to automatically collect four to six milliliters of blood frpm their patients for laboratory testing. However, the typical lab test usually needs less than half a milliliter of blood, resulting in over 90% of the drawn blood being wasted. There are commercially available tubes that draw less blood due to a weaker vacuum inside, which can be particularly beneficial in intensive care units (ICUs). In ICUs, patients often need numerous blood samples collected multiple times a day, which can lead to a significant loss of blood. This loss can result in anemia, as ICU patients are often unable to regenerate red blood cells quickly enough. As a result, these patients frequently require blood transfusions. Now, a world-first clinical trial has come up with an easy way to save blood.

The trial by researchers at the University of Ottawa (Ontario, Canada) involved over 27,000 patients across 25 adult ICUs. The study showed that the use of "small-volume" tubes for blood collection reduced the need for a blood transfusion in nearly one out of every 10 patients. The trial was innovative in its design, as it involved randomizing different ICUs to use either small-volume blood collection tubes or regular tubes for different periods of time, before switching to the other tubes. The researchers tracked blood transfusion data for each patient through electronic medical records, excluding those who were in the ICU for less than 48 hours.

While previous observational studies have suggested the benefits of using small-volume tubes, this is the first clinical trial to rigorously evaluate their efficacy in a hospital environment. The trial not only found that the use of these tubes reduced the incidence of anemia and the need for blood transfusions, but also confirmed that the lesser amount of blood drawn did not affect the quality of lab tests. After excluding data collected during the peak of the pandemic, the findings remained consistent, albeit not statistically significant. The research is significant because anemia can cause patients to feel weak and tired, potentially leading to other complications and extended hospital stays. Although blood transfusions are generally effective in treating anemia, they can occasionally lead to rare but serious side effects like respiratory difficulties, allergic reactions, and infections.

“This trial showed that we can save one blood transfusion for every 10 ICU patients by simply switching to small-volume tubes for blood collection,” said senior author Dr. Deborah Siegal, a scientist and hematologist at The Ottawa Hospital who led the trial. “At a time when everyone is trying to find ways to make health care more sustainable, and preserve our supply of blood products, this study provides a simple solution that can be implemented without additional cost or negative effects.

Related Links:
University of Ottawa 

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.